Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidence.
Cardiac Catheterization
/ adverse effects
Clinical Trials as Topic
Evidence-Based Medicine
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation
/ adverse effects
Hemodynamics
Humans
Mitral Valve
/ diagnostic imaging
Mitral Valve Insufficiency
/ diagnostic imaging
Postoperative Complications
/ etiology
Recovery of Function
Registries
Risk Factors
Treatment Outcome
functional mitral regurgitation
mitral valve
randomized trial
transcatheter mitral valve repair
Journal
The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
12
12
2019
revised:
06
02
2020
accepted:
17
02
2020
pubmed:
4
5
2020
medline:
3
11
2021
entrez:
4
5
2020
Statut:
ppublish
Résumé
Two trials (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation Trial and Percutaneous Repair with the MitraClip Device for Severe Functional/Secondary Mitral Regurgitation Trial) were published in 2018 evaluating the effectiveness and safety of transcatheter repair for patients with heart failure with significant functional mitral regurgitation, which yielded different results. This article reviews the strength of the evidence, differences in trial designs, ethical and implementation implications, and delineates future research needs to help guide the appropriate dissemination of transcatheter repair for functional patients with mitral regurgitation. The National Heart, Lung, and Blood Institute convened a workshop of interdisciplinary experts to address these objectives. Transcatheter repair of functional mitral regurgitation can provide significant benefits in terms of heart failure hospitalizations, survival, and quality of life when appropriate heart failure candidates with moderate to severe or severe mitral regurgitation while on optimal guideline-directed medical therapy can be identified. Key ingredients for success are preoperative evaluation and management and postoperative care by an interdisciplinary heart team. Given the discordance observed between trials, ongoing innovation in patient management, and potential expansion of indications for use, the evidence base must be expanded to optimize appropriate implementation of this complex therapy. This will require more complete capture of outcome data in real-world settings for all eligible candidates whether or not they receive this therapy. Inevitably, the indications for use of this therapy will expand, as will the devices and therapeutic approaches for this population, necessitating the study of comparative effectiveness through randomized trials or observational studies. Moreover, given the substantial variations in care delivery, conducting implementation research to delineate characteristics of the optimal care model would be of benefit.
Identifiants
pubmed: 32359794
pii: S0022-5223(20)30630-9
doi: 10.1016/j.jtcvs.2020.02.132
pmc: PMC7935447
mid: NIHMS1675742
pii:
doi:
Types de publication
Consensus Development Conference, NIH
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1504-1511Subventions
Organisme : NHLBI NIH HHS
ID : U01 HL088942
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2020. Published by Elsevier Inc.
Références
J Am Coll Cardiol. 2019 May 7;73(17):2123-2132
pubmed: 30894288
N Engl J Med. 2014 Dec 4;371(23):2178-88
pubmed: 25405390
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
N Engl J Med. 2018 Dec 13;379(24):2307-2318
pubmed: 30280640
JACC Cardiovasc Imaging. 2019 Feb;12(2):353-362
pubmed: 30553663
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Eur J Heart Fail. 2019 Dec;21(12):1619-1627
pubmed: 31476260
J Am Coll Cardiol. 2014 Dec 30;64(25):2792-801
pubmed: 25541133
JACC Cardiovasc Interv. 2019 Jul 22;12(14):1342-1352
pubmed: 31320029
N Engl J Med. 2018 Dec 13;379(24):2297-2306
pubmed: 30145927
JACC Cardiovasc Interv. 2019 Jul 22;12(14):1353-1355
pubmed: 31320030
J Thorac Cardiovasc Surg. 2019 Jul;158(1):76-81
pubmed: 30773386
JACC Heart Fail. 2019 Jun;7(6):522-526
pubmed: 31078477
J Am Coll Cardiol. 2020 Jul 7;76(1):96-117
pubmed: 31857196
Am Heart J. 2018 Nov;205:1-11
pubmed: 30134187
N Engl J Med. 2018 Dec 13;379(24):2374-2376
pubmed: 30575469
N Engl J Med. 2014 Jan 2;370(1):23-32
pubmed: 24245543